These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11791087)

  • 1. Effects of long-term and reduced-dose hormone replacement therapy on endothelial function and intima-media thickness in postmenopausal women.
    Hashimoto M; Miyao M; Akishita M; Hosoi T; Toba K; Kozaki K; Yoshizumi M; Ouchi Y
    Menopause; 2002; 9(1):58-64. PubMed ID: 11791087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term hormone replacement therapy delays the age related progression of carotid intima-media thickness in healthy postmenopausal women.
    Takahashi K; Tanaka E; Murakami M; Mori-Abe A; Kawagoe J; Takata K; Ohmichi M; Kurachi H
    Maturitas; 2004 Oct; 49(2):170-7. PubMed ID: 15474762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women.
    Tremollieres FA; Cigagna F; Alquier C; Cauneille C; Pouilles J; Ribot C
    Atherosclerosis; 2000 Nov; 153(1):81-8. PubMed ID: 11058702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid artery intima thickness and flow velocity after discontinuation of hormone replacement therapy in postmenopausal women: follow-up study.
    Vidović IP; Demarin V; Grubisić G; Kuna K; Huzjan AL
    Croat Med J; 2001 Feb; 42(1):54-7. PubMed ID: 11172656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of low-dose medroxyprogesterone acetate and oral estrogen does not affect endothelial function in the forearms of postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Nagai N; Chayama K; Ohama K
    Menopause; 2002; 9(5):360-6. PubMed ID: 12218725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of different hormone treatment on endothelial function in healthy postmenopausal women.
    Akman L; Duygu H; Akercan F; Ulukus M; Ozerkan F; Akin M
    Gynecol Endocrinol; 2013 Sep; 29(9):867-72. PubMed ID: 23875965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal estrogen therapy counteracts normal aging effects on intima thickness, media thickness and intima/media ratio in carotid and femoral arteries. An investigation using noninvasive high-frequency ultrasound.
    Naessen T; Rodriguez-Macias K
    Atherosclerosis; 2006 Dec; 189(2):387-92. PubMed ID: 16460740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women.
    Hayward CS; Samaras K; Campbell L; Kelly RP
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):699-703. PubMed ID: 11465656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Nabulsi AA; Folsom AR; Szklo M; White A; Higgins M; Heiss G
    Circulation; 1996 Oct; 94(8):1857-63. PubMed ID: 8873660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
    Hypertens Res; 2005 Jul; 28(7):579-84. PubMed ID: 16335886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women.
    Koh KK; Ahn JY; Jin DK; Yoon BK; Kim HS; Kim DS; Shin MS; Son JW; Choi IS; Shin EK
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1459-64. PubMed ID: 12231566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial.
    Lindenfeld EA; Langer RD
    Obstet Gynecol; 2002 Nov; 100(5 Pt 1):853-63. PubMed ID: 12423841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
    Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G
    Menopause; 2010; 17(3):622-9. PubMed ID: 20215977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
    Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
    Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy].
    Liu JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):240-3. PubMed ID: 12905731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.
    Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):571-6. PubMed ID: 14699021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.